Effect of Two Kinds of Different Combined Oral Contraceptives Used on Bone Mineral Density in Women of Reproductive Age

Journal of Reproduction and Contraception

Volumn 22, Issue 3, 2011, Pages 145-151

  Liu, Rui jian ^a   Gai, Ling ^b   Jia, Yi fang ^b   Gai, Ping ^a   Yu, Xiao jie ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Shandong Provincial Institute of Science and Technology for Family Planning   (China)

Author keywords

Bone mineral density (BMD); Combined oral contraceptives (COC); Ethinylestradiol cyproterone acetate; Ethinylestradiol desogestrel

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE;

ADULT; ARTICLE; BONE DENSITY; CONDOM; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LUMBAR SPINE; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

EID: 84856849730     PISSN: 10017844     EISSN: 18767966     Source Type: Journal    
DOI: 10.1016/S1001-7844(12)60010-8     Document Type: Article

References (14)

1. Catherine d'Arcangues, Department of Reproductive Health and Research WHO statement on hormonal contraception and bone health. Contraception 2006, 73(5):443-444.
2. Clark MK, Sowers MF, Nichols S, Levy B Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2004, 82(6):1580-1586.
3. Nappi C, Di Spiezio SA, Greco E, et al. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol 2005, 105(1):53-60.
4. Recker RR, Davies KM, Hinders SM, et al. Bone gain in young adult women. JAMA 1992, 268(17):2403-2408.
5. Reed SD, Scholes D, LaCroix AZ, et al. Longitudinal changes in bone density in relation to oral contraceptive use. Contraception 2003, 68(3):177-182.
6. Paoletti AM, Orru M, Lello S, et al. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women. Contraception 2004, 70(4):293-298.
7. Berenson AB, Breitkopf CR, Grady JJ, et al. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol 2004, 103(5):899-906.
8. Barad D, Kooperberg C, Wactawski-Wende J, et al. Prior oral contraception and postmenopausal fracture: a women's health initiative observational cohort study. Fertil Steril 2005, 84(2):374-383.
9. Vessey M, Mant J, Painter R Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study. Contraception 1998, 57(4):231-235.
10. Berenson AB, Rickert VR, Grady JJ A prospective study of the effects of oral and injectable contraception on bone mineral density. Obstet Gynecol 2000, 95(6):S6.
11. Kiley J, Hammond C Combined oral contraceptives: a comprehensive review. Clin Obstet Gynecol 2007, 50(4):868-877.
12. Garnero P, Sornay-Rendu E, Delmas PD Decreased bone turnover in oral contraceptive users. Bone 1995, 16(5):499-503.
13. Tinelli FG, Tinelli A, Sena T Clinical effects of hormone replacement therapy with estradiol valerate and cyproterone acetate in perimenopausal women. Minerva Ginecol 2002, 54(1):67-73.
14. Komulainen MH, Kroger H, Tuppurainen MT, et al. HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas 1998, 31(1):45-54.